Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Recurrent × palbociclib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 135 Neoplasm Metastasis 21 Neoplasms 17 Ovarian Neoplasms 11 Sarcoma 10 Squamous Cell Carcinoma of Head and Neck 8 Pancreatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Endometrial Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 5 Head and Neck Neoplasms 5 Breast Diseases 5 Sarcoma, Ewing 4 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Medulloblastoma 4 Lung Neoplasms 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 3 Rhabdomyosarcoma 3 Rhabdoid Tumor 3 Osteosarcoma 3 Neuroblastoma 3 Neoplasms by Site 3

Interventions

palbociclib 1 S 1 (combination) 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03820830 2025-03-07

POLAR

ETOP IBCSG Partners Foundation

Phase 3 Active not recruiting

Breast Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡